The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Grant - II | Alive

Total Raised


Last Raised

$23.37M | 7 mos ago

About Apogenix

Apogenix, a spin-out from the German Cancer Research Center (DKFZ), is developing protein therapeutics for the treatment of cancer and inflammatory diseases based either on the targeted modulation of apoptosis (programmed cell death) or on blocking the growth of tumor cells. The company's lead product candidate APG101 is being developed for the treatment of Glioblastoma Multiforme (GBM), the most common and aggressive type of primary brain tumor.

Apogenix Headquarter Location

Im Neuenheimer Feld 581

Heidelberg, 69120,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Apogenix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Apogenix is included in 2 Expert Collections, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Apogenix Patents

Apogenix has filed 42 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Proteins
  • Transcription factors
patents chart

Application Date

Grant Date


Related Topics




Clusters of differentiation, Transcription factors, Proteins, Immunology, Monoclonal antibodies


Application Date


Grant Date



Related Topics

Clusters of differentiation, Transcription factors, Proteins, Immunology, Monoclonal antibodies



Latest Apogenix News

Glioblastoma Multiforme Treatment Market To Garner Brimming Revenues By 2020 – 2027 | Crunchbase Inc., Exelixis, Eisai, Apogenix GmbH

Oct 26, 2020

Search jobs 26-Oct-2020 Glioblastoma Multiforme Treatment Market To Garner Brimming Revenues By 2020 – 2027 | Crunchbase Inc., Exelixis, Eisai, Apogenix GmbH Glioblastoma multiforme treatment market is expected to gain market growth at a potential rate of 5.80% in the forecast period of 2020 to 2027. The growing prevalence of brain disorders will act as a vital factor to the growth of the glioblastoma multiforme treatment market. Key Market Competitors Covered in the Report are : Arbor Pharmaceuticals, LLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Roche Holding AG, Merck Sharp & Dohme Corp., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Activartis GmbH, Agenus Inc., Cavion LLC, Celldex Therapeutics, Inc., Crunchbase Inc., Exelixis, Inc., Eisai, Apogenix GmbH, VASCULAR BIOGENICS Ltd, Pfizer Inc, CANbridge Life Sciences Ltd., and GlaxoSmithKline plc among other domestic and global players. Access insightful study with over 100+ pages, list of tables & figures, profiling 10+ companies. Ask for Free Sample Copy Of Glioblastoma Multiforme Treatment Market Report@ Regional Analysis Includes: Europe (Germany, France, UK, Russia, and Italy, etc.) Market Size and/or Volume North America (The United States, Mexico, and Canada) Market Size and/or Volume South America (Brazil, Argentina, Columbia, etc.) Market Size and/or Volume The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) Market Size and/or Volume For producing such excellent Glioblastoma Multiforme Treatment Market research report, principal attributes such as highest level of spirit, practical solutions, dedicated research and analysis, innovation, talent solutions, integrated approaches, most advanced technology and commitment plays a key role. By thinking from the customer point of view, a team of researchers, analysts and industry experts work carefully to generate this market report. What is more, the statistical data covered in this report is interpreted with the help of most established tools such as SWOT analysis and Porter’s Five Forces Analysis. Glioblastoma Multiforme Treatment Market is the promising and most suitable market research report for the clients. Global Glioblastoma Multiforme Treatment Market Scope and Market Size Glioblastoma multiforme treatment market is segmented on the basis of drug type, route of administration, molecule and end-user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. Based on drug type, the glioblastoma multiforme treatment market is segmented into temozolomide, bevacizumab, carmustine, radiosensitizers, and others. Based on route of administration, the glioblastoma multiforme treatment market is segmented into oral, parental, and others. Based on molecule, the glioblastoma multiforme treatment market is segmented into small molecule, biologics, and others. Based on end-user, the glioblastoma multiforme treatment market is segmented into hospitals/clinics, ambulatory surgical centers, and others. Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert@ Key Pointers Covered in Glioblastoma Multiforme Treatment Market Industry Trends and Forecast to 2020 – 2027 Market Size Some of the major objectives of this report: 1) To provide a detailed analysis of the market structure along with the forecast of the various segments and sub-segments of the global Glioblastoma Multiforme Treatment Market. 2. To provide insights about factors affecting market growth. To analyze the Glioblastoma Multiforme Treatment Market based on various factors- price analysis, supply chain analysis, porter five force analyses, etc. 3. To provide historically and forecast revenue of the Glioblastoma Multiforme Treatment Market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and the Rest of the World. 4. Country-level analysis of the market with respect to the current market size and future prospective. 5. To provide country-level analysis of the market for segment by application, product type and sub-segments. 6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. 7. Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Glioblastoma Multiforme Treatment Market. New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request FREE TOC at @ Research Methodology: Global Glioblastoma Multiforme Treatment Market Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry. The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts. Key Insights in the report: Complete and distinct analysis of the market drivers and restraints Key market players involved in this industry Detailed analysis of the Market Segmentation Competitive analysis of the key players involved Key Questions Answered: What are the key driving factors of the most profitable regional market? Which are the leading segments of the global market? How will the global market advance in the coming years? What are the main strategies adopted in the global market? What is the nature of competition in the global market? What growth impetus or acceleration market carries during the forecast period? Which region may hit the highest market share in the coming era? What trends, challenges, and barriers will impact the development and sizing of the market? A full report of Global Glioblastoma Multiforme Treatment Market is available at: Customization Available : Global Glioblastoma Multiforme Treatment Market Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report. About Us: An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process. Contact: UK: +44 208 089 1725 Hong Kong: +852 8192 7475

  • When was Apogenix founded?

    Apogenix was founded in 2005.

  • Where is Apogenix's headquarters?

    Apogenix's headquarters is located at Im Neuenheimer Feld 581, Heidelberg.

  • What is Apogenix's latest funding round?

    Apogenix's latest funding round is Grant - II.

  • How much did Apogenix raise?

    Apogenix raised a total of $41.74M.

  • Who are the investors of Apogenix?

    Investors of Apogenix include dievini Hopp BioTech Holding & Co., Bundesministerium fur Bildung und Forschung, Bundesministerium für Gesundheit, BMBF GOBio and Deutsches Krebsforschungszentrum.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.